Tenomix Inc.

🚀 Breaking news! 🚀   After an extensive search and reviewing many outstanding candidates, we're thrilled to announce that Jamie Tremaine has joined the Tenomix team as our new Director of Software Engineering! 🎉   Jamie is a seasoned mechatronics engineer with over a decade of experience in machine learning and computer vision. As a serial entrepreneur, he has founded seven ventures, including LabLight AR and GestSure, both groundbreaking products in the laboratory and med-tech sectors. From developing interactive augmented reality systems for molecular biologists to creating touchless controls for surgeons, Jamie’s innovations have transformed how technology enhances scientific and clinical workflows.   His expertise and entrepreneurial spirit will be invaluable as we continue our mission to revolutionize pathology with cutting-edge technology. Welcome aboard, Jamie! We're excited to have you join us in our fight for better cancer care. 💪   #Tenomix #HealthcareAI #TeamGrowth #Innovation #NewHire #PathologyTech #MedTech

In this edition of A Founder's Diary newsletter, we have a takeover from Saumik Biswas, PhD, the CEO and co-founder of Tenomix Inc. At Tenomix, they are on a mission to develop novel medical technologies that address inefficiencies in the pathology workflow, reduce healthcare costs, and optimize cancer care for patients. They're currently building an automated, AI-driven robotic solution designed to streamline the manual lymph node detection process in excised cancer tissues. Keep reading to learn more about: - What the team is working on including R&D, manufacturing, collaborating with clinical partners, preparing for the AdvaMed MedTech Conference, and more - How they embrace uncertainty in the startup environment - How they achieve their goals and priorities through the Entrepreneurial Operating System and Level 10 (L10) meetings - Saumik's top tips for balancing founder life and mental health - His hobbies and how he likes to find time outside of work to go traveling, hiking, breakdancing, and more Let's dive in!

👉 Our founder & COO Eveline Pasman will be attending the AdvaMed MedTech Conference in Toronto next week (Oct 14-17). Please feel free to connect with her through LinkedIn or the MyMedTech app if you are interested to talk anything ✨ AI in health care, regulatory, and/or QMS ✨ related, or to simply catch up in person! 🚨 Our 3 other founders - Saumik Biswas, PhD, Mike Lavdas, and Sherif Abdou - will also be attending, so make sure to keep an 👀 out for them as well! #MedTechCon #MTC2024

Last week, we visited our client Tenomix Inc. in London, Ontario! Tenomix’s vision is to “be at the forefront of pathology innovation," and we are proud and excited to be providing critical #IP support to see Tenomix grow and make significant impacts in Ontario's #MedTech sector. 👏 Thank you Saumik Biswas, PhD, CEO & Founder of Tenomix, for showing us around your lab and demonstrating your upcoming project. Learn more about Tenomix here: www.tenomix.com Ready for #IP support to grow your own Ontario-based business? Apply now: www.ip-ontario.ca/apply

Earlier today, I had a call with one of our clinical collaborators down south, and he mentioned how special the Tenomix team is—the level of cohesiveness and passion we share while building a truly innovative technology. That really resonated with me.
 I feel incredibly fortunate to be surrounded by some of the greatest people I know. It’s truly rewarding, beyond words, to be part of a team and a larger community that’s fully committed to pushing the boundaries of medical innovation.
 I wanted to share a recent photo of our growing team (top photo) from a few weeks ago, taken to celebrate Tenomix Inc. turning 3 years old with our BioNext friends 🥳🎉 It’s been a wild ride, no doubt. But the milestones we’ve hit in just three years make it feel like we’re a 10-year-old company (maybe that’s why I’m noticing more grey hairs).
 Just THIS year, we’ve accomplished some pretty amazing things that leave me speechless at times: - Closed our first (oversubscribed) $2M+ financing round, during one of the toughest economic conditions. - Filed national patent applications for our core technology in 10 key regions, based on our earlier PCT. - Secured more than $1.59M in grant funding. - Continued working with some of the top hospitals in North America and strengthening our collaborations. - Attended over six conferences and pitch events in the first two quarters, meeting with more than 60 new investors and securing new leads for manufacturing and clinical collaboration. - Recently partnered with a solid contract manufacturer to build the next version of our device—stay tuned! - Maintained commitments with over six incubators and completed four new accelerators, including NEXT AI (highly recommend this program for the AI-focused startups in my network). - Conducted multiple usability tests and made rapid iterations to our prototype. - Grew the team by more than 800% in terms of full-time employees. - Featured in prominent publications like the Toronto Star, The Logic and among others. - Offered opportunities to over 49 interns in the last three years, who have made significant contributions to different parts of the business. - Completed more than 73 experiments over 3 years, which taught us so much about our technology and revealed exciting new clinical applications for it. 😉
 I know I sound like a broken record, but we couldn’t have done any of this without our incredible community partners. Whether it’s providing prototyping support, office space, funding, mentorship, or invaluable teachings, you’ve been the rock-solid foundation that allows us to focus on what we do best—innovating and building technologies that will leave a lasting impact on pathology staff, hospitals, and patients worldwide.
 And a special shoutout to our investors and mentors—you guys are the best! You believed in our vision from the start, and it’s been such an exciting journey already. I can’t wait to keep building this company with our community and take it to the moon 🚀🌕

🚨Appreciation post🚨 Early-stage capital is the lifeblood of any startup, and it's especially critical for those in the medical space. We are deeply grateful to our early-stage investors (FACIT, Phoenix Fire, The Firehood, Ontario Centre of Innovation, OBIO and our angel investors) who believed in our mission, our innovative technology, and our team from day one. A special thank you to the Archangel Network of Funds for the wonderful blog post, and to all of our investors, clinical partners, and community supporters for empowering us to drive new medical innovations that will improve patient care. Your belief in us makes all the difference! 🙏

A celebration of community at Venture Day 2024… 🎉 We were excited to host Venture Day 2024, showcasing 90 ventures, 12 pitches, and engaging over 400 investors, ecosystem partners, and supporters. This event allowed us to celebrate the remarkable growth and resilience of our 2024 cohort. The event featured remarks from Founding Chairman Reza Satchu, Academic Director Ajay Agrawal, and Harvard Kennedy School’s David Deming, reaffirming our mission to drive prosperity and innovation within Canada’s economy. Congratulations to Vishar Yaghoubian (NEXT 36 24’), our valedictorian and People’s Choice Award winner - supported by Richard Abboud and Reza Satchu. Congratulations to our Nanji Innovators, Arlyne James, Nicole Baranowski, Saumik Biswas, Rae Jeong, Connor Ross, and Vishar Yaghoubian . A special congratulations to Kate Wallace, the recipient of the 2024 Satchu Prize. A heartfelt thank you to EY, Hatch and Air Canada for your ongoing support of our endeavors. To our alumni and mentors, your dedication to our program strengthens our community and we are forever grateful. We’re immensely proud of all the founders in the 2024 cohort and look forward to continuing to support their entrepreneurial journeys. Interested in fueling the next wave of high-impact entrepreneurs? You can donate here … nextcanada.com/donate. ___ #NEXTCanada #VentureDay #Entrepreneurship MaRS Discovery District Don Walker Michael Yu Anthony Azrak Javad Siahkamari Michael Stych Quinn Dai Rae Jeong Saumik Biswas, PhD Mark Aquilino Benjamin Sanders Niraj Mathur Tanya Butt Deona D.

We're incredibly grateful to the Ontario Centre of Innovation and our early funders for believing in our mission. Your continuous support has been the driving force behind our rapid growth and the incredible progress we've made as a team. Together, we’re moving mountains, and we can’t wait to see what’s next! 🚀 🌕

If you haven't seen it yet, check out our CEO Saumik Biswas, PhD sharing his personal journey behind medical innovation and the work our team is doing at Tenomix in a recent Toronto Star article: https://lnkd.in/gsNhaqNm 🗞 📸 Thank you MaRS Discovery District and the Toronto Star for the opportunity to showcase our company's commitment to medical innovation!

🚨 🚨 We are hiring for a Software Engineer position! 🚨 🚨 ➡ For the Job Description & To Apply 👉 https://lnkd.in/gi5DvU2Q We are looking to expand the software capabilities of our team, now that we have successfully closed our oversubscribed $2M, all-🇨🇦 seed round! Are you a self-motivated, energetic, and passionate software engineer with medical device software development experience - this might be the job for you ✅ Come join Tenomix’s R&D team to help develop a platform technology that utilizes robotics, ultrasound imaging, and machine learning to locate lymph nodes in surgically removed colon cancer tissues. A technology that will ultimately benefit hospitals, pathology labs, and cancer patients worldwide. #medicaldevices #softwaredevelopment #softwareengineering #hiring #startup